Gengos Andrew (CIK 0001563623)

Latest company ownership

Shares held
97,532
Last filed at
Sep 5, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4
Shares held
25,000
Last filed at
Jun 30, 2025
Confidence Score
52.3
2025Q4
Confidence Score History
2025Q2 2025Q4
Shares held
1,175
Last filed at
Feb 13, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 27, 2025 Jun 30, 2025 Terns Pharmaceuticals, Inc. CFO Buy 91.3 +10,000 66.67% ✗ $39.3K
Jun 13, 2025 Jun 16, 2025 Terns Pharmaceuticals, Inc. CFO Buy 95.0 +15,000 100.00% ✗ $57.1K
May 20, 2024 Sep 5, 2024 Athira Pharma, Inc. CFO Sell 90.0 +13,728 16.38% ✗ $720
Jan 4, 2024 Feb 16, 2024 Athira Pharma, Inc. CFO Sell 82.5 +3,792 4.74% ✗ $3.5K
Jan 4, 2023 Jan 8, 2024 Athira Pharma, Inc. See Below Sell 82.5 +3,792 4.74% ✗ $3.5K
Jun 7, 2023 Jun 9, 2023 Athira Pharma, Inc. See Below Buy 95.0 +15,000 23.07% ✗ $51.4K
Jun 2, 2023 Jun 6, 2023 Athira Pharma, Inc. See Below Buy 95.0 +65,012 100.00% ✗ $191.6K
Dec 31, 2016 Feb 13, 2017 EOM Pharmaceutical Holdings, Inc. Director Sell 47.5 -3,284 -33.83% ✗ $6.7K
Nov 30, 2015 Dec 2, 2015 EOM Pharmaceutical Holdings, Inc. CEO Buy 82.5 +10,000 4.38% ✗ $4.4K
Feb 18, 2015 Feb 20, 2015 EOM Pharmaceutical Holdings, Inc. CEO Buy 91.3 +41,333 111.71% ✗ $24.8K
Aug 14, 2014 Aug 14, 2014 EOM Pharmaceutical Holdings, Inc. CEO Buy 90.0 +10,000 37.04% ✗ $9K
Dec 18, 2013 Dec 18, 2013 EOM Pharmaceutical Holdings, Inc. CEO Buy 91.3 +27,000 100.00% ✗ $19.4K